Intrinsic Value of S&P & Nasdaq Contact Us

Prelude Therapeutics Incorporated PRLD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.25
+42%

Prelude Therapeutics Incorporated (PRLD) has 18 known insider and institutional holders on record. The largest holder is ORBIMED ADVISORS LLC with 10,119,756 shares. Other notable holders include Vaddi Krishna and Lim Bryant David.

Over the last 12 months, insiders have made 16 transactions in PRLD stock — 11 buys (valued at $4.06M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

PRLD Insider Ownership

Top Holder
ORBIMED ADVISORS LLC
10,119,756 shares
Buys (12 mo)
11
$4.06M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 69%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Orbimed Advisors Llc 10 Percent Owner 10,119,756 2023-05-24
100%
2 Vaddi Krishna CEO 837,000 2026-02-05
8%
3 Lim Bryant David CLO, CFO, Corp Sec. 275,000 2026-02-05
3%
4 Scherle Peggy Chief Scientific Officer 230,000 2026-02-05
2%
5 Combs Andrew Chief Chemistry Officer 230,000 2026-02-05
2%
6 Chardonnet Laurent Chief Financial Officer 150,000 2024-03-04
1%
7 Sandor Victor Director 121,285 2025-11-07
1%
8 Piper Brian Chief Financial Officer 115,650 2021-07-22
1%
9 Mauro David J Chief Medical Officer 95,000 2021-07-22
1%
10 Morosini Deborah EVP, Chief of Clinical Affairs 90,000 2022-02-17
1%
11 Baker Bros. Advisors Lp 10 Percent Owner 76,000 2025-06-13
1%
12 Babler Martin Director 38,000 2025-06-13
0%
13 Friedman Paul A Director 38,000 2025-06-13
0%
14 Dier Mardi Director 38,000 2025-06-13
0%
15 Bonita David P 10 Percent Owner 38,000 2025-06-13
0%
16 Baker Brothers Life Sciences Lp Director 34,300 2022-06-22
0%
17 Huang Jane President, CMO 18,750 2025-10-07
0%
18 Pierce Christopher EVP and Chief of Business Oper 3,750 2021-09-07
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-05 Brusky Sean P. Chief Business Officer Unknown 275,000 - -
2026-02-04 Combs Andrew Chief Chemistry Officer RSU Award 230,000 $2.30 $529K
2026-02-04 Vaddi Krishna CEO RSU Award 837,000 $2.30 $1.93M
2026-02-04 Scherle Peggy Chief Scientific Officer RSU Award 230,000 $2.30 $529K
2026-02-04 Lim Bryant David CLO, CFO, Corp Sec. RSU Award 275,000 $2.30 $632.5K
2025-11-05 Sandor Victor Director RSU Award 121,285 $1.39 $168.59K
2025-10-17 Dorton Katina Officer Unknown - - -
2025-10-04 Huang Jane President, CMO Option Exercise (Sell) 9,375 - -
2025-07-04 Huang Jane President, CMO Option Exercise (Sell) 9,375 - -
2025-06-12 Scherer Paul C Officer Unknown - - -
2025-06-12 Sandor Victor Director RSU Award 38,000 $1.04 $39.52K
2025-06-12 Dier Mardi Director RSU Award 38,000 $1.04 $39.52K
2025-06-12 Bonita David P 10 Percent Owner RSU Award 38,000 $1.04 $39.52K
2025-06-12 Babler Martin Director RSU Award 38,000 $1.04 $39.52K
2025-06-12 Baker Bros. Advisors Lp 10 Percent Owner RSU Award 76,000 $1.04 $79.04K
2025-06-12 Friedman Paul A Director RSU Award 38,000 $1.04 $39.52K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message